1.Review published literature regarding RKF and decreased mortality in the hemodialysis population.
2.Evaluate whether RKF can be “clinically negligible” or if any degree of RKF is “metabolically significant.”
3.Reframe how nephrologists view RKF and its relationship with certain non-urea solutes.
Session date: 
08/09/2017 - 4:00pm to 5:00pm CDT
UCMC S-534
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Stephanie Toth-Manikowski, MD